Free shipping on orders over $75Free shipping on orders over $75
DKGlow was born from a simple question: why aren’t the most promising ingredients in research showing up in the products on shelves?
At DKGlow, we are driven by a mission to transform skincare and wellness through the power of science and nature. Founded by Dr. Dorra Frikha-Benayed — a scientist with a PhD in Biomedical Engineering from City College of New York — DKGlow is rooted in groundbreaking research in cellular and molecular bioengineering.
Dr. Frikha-Benayed's published work examines bone-cell metabolism, mitochondrial activity, and oxidative stress. Her record includes first-author research in Bone and coauthored studies in PNAS and Aging.
At DKGlow, she formulates the methylene-blue face, body, and hair-care products. Her academic background informs that work. Research on an ingredient or on bone cells is distinct from testing a finished skincare formula or a device.
Dr. Dorra Frikha-Benayed
Founder & Formulator, DKGlow · Biomedical Engineering, CCNY
IBTimes · March 2026
“The mitochondria is the powerhouse of the cell. We're just here to make sure it keeps powering.”
These studies document her work in mitochondrial biology, bone cells, and cellular bioenergetics. They do not report clinical trials of DKGlow skincare or devices.
Poudel SB, Frikha-Benayed D, Ruff RR, et al.
Cell experiments showed biological effects, but the mouse studies did not show improved bone mineral density or skeletal morphology with the tested interventions. This was not a skincare trial.
Read paperLewis KJ, Frikha-Benayed D, Louie J, et al.
Mouse research on how bone cells respond to mechanical loading through calcium signals. Dr. Frikha-Benayed is a coauthor; this study did not test skincare products.
Read paperFrikha-Benayed D, Basta-Pljakic J, Majeska RJ, Schaffler MB
Examines regional differences in bone-cell metabolism and mitochondrial activity. It documents Dr. Frikha-Benayed’s research background, not finished-product skincare efficacy.
Read paperJournal articles, conference contributions, and a published patent application are identified separately below. A patent application is not clinical evidence or a regulatory approval. Full research profile on Google Scholar .
Liu Z, Solesio ME, Schaffler MB, Frikha-Benayed D, et al.
Osteocyte oxidative stress following estrogen loss, microdamage and disuse
Presenter: Dr. Dorra Frikha-Benayed
Frikha-Benayed D, Lapshina M, Majeska R, Schaffler M
Method of treating or preventing osteoporosis (App. 15/618,783)
Inventors: Dorra Frikha-Benayed and Mitchell B. Schaffler
Acute increase in osteocyte oxidative stress at focal microdamage site in bone
Frikha-Benayed D, Basta-Pljakic J, Majeska RJ, Schaffler MB
Cabahug-Zuckerman P, Frikha-Benayed D, Majeska RJ, et al.
Methylene blue and photobiomodulation have separate research literatures. Studying both does not establish that combining our products improves results.
Xiong and colleagues studied methylene blue in cultured human skin cells and reconstructed skin. They reported lower oxidative-stress markers and changes in cell growth and skin-model properties, rather than outcomes from a human skincare trial.
Xiong et al. (2017), Scientific Reports. Dr. Frikha-Benayed is not an author of this study.
Photobiomodulation research examines responses to low-intensity light under defined conditions. The light source, dose, and study population matter; a review of this field does not demonstrate the performance of every device in our catalog.
Hamblin MR (2017), AIMS Biophysics — a review of mechanisms and inflammation research.
Every formulation is rooted in peer-reviewed research on mitochondrial function and cellular health.
Explore the ingredient lists and usage directions on our topical product pages to choose what fits your routine.
Dr. Dorra Frikha-Benayed is the founder of DKGlow and the formulator of its methylene-blue topical products.
Explore our skincare and device range. Free shipping on orders $75+.
Browse our full line of Methylene Blue and Infrared products.